Skip to main content
. 2023 Mar 14;3(2):198–207. doi: 10.1016/j.jacasi.2022.12.007

Figure 3.

Figure 3

Cost-Effectiveness Acceptability Curves

Probabilistic sensitivity analyses were performed on base-case and scenario, assuming no difference in cardiovascular mortality. The dashed lines represent the willingness-to-pay (WTP) threshold of $30,581. The curves show the probabilities that each monotherapy is cost-effective at varying cost-effectiveness threshold ratios. QALY = quality-adjusted life-year; USD = U.S. dollar.